Condition: Irritable Bowel Syndrome · Fecal Microbiota Transplantation · Sponsor: Helsinki University Central Hospital
Previous studies have shown that stool transplantation (FMT) have positive effect in symptoms for some patients with irritable bowel syndrome (IBS). Studies have shown that it is possible by FMT to reverse the microbiome of the recipient's intestine in the direction of the microbiome of the donor. The effect on eating habits for engraftment of microbiome by FMT is unknown. The purpose of this study is to investigate whether FMT relieves FODMAP diet extension without worsening intestinal symptoms in IBS patients.
This description comes directly from the study's public registry record.
Perttu Arkkila, Professor · +358504272272 · perttu.arkkila@hus.fi
Perttu Lahtinen, Md · +358381911 · perttu.lahtinen@phhyky.fi
Always discuss trial participation with your own doctor first.
| Helsinki University Hospital | Helsinki, Helsinki and Uusimaa, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05361785